Carcinoid syndome - Articles and news items

FDA extends PDUFA date for telotristat etiprate for the treatment of carcinoid syndrome

Industry news / 20 September 2016 / Niamh Louise Marriott, Digital Content Producer

In a notice from the FDA, the Prescription Drug User Fee Act date for its Priority Review of telotristat etiprate has been extended by three months…

 

The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...
+